HTA151 Rapid Review of Published Economic Evaluations of Larotrectinib and Entrectinib: Current Practices to Overcome Challenges in Health Technology Assessment of Tumor-Agnostic Treatments
Abstract
Authors
T Zelei S Ashrafganjouei G Kovacs